Clinical significance of B7-H4 expression in matched non-small cell lung cancer brain metastases and primary tumors

References

• JemalACenterMMDeSantisCWardEMGlobal patterns of cancer incidence and mortality rates and trendsCancer Epidemiol Biomarkers Prev20101981893190720647400
   PubMed Web of Science ®Google Scholar
• SiegelRNaishadhamDJemalACancer statistics, 2012CA Cancer J Clin2012621102922237781
   PubMed Web of Science ®Google Scholar
• RamalingamSSOwonikokoTKKhuriFRLung cancer: new biological insights and recent therapeutic advancesCA Cancer J Clin20116129111221303969
   PubMed Web of Science ®Google Scholar
• MamonHJYeapBYJannePAHigh risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiationJ Clin Oncol20052371530153715735128
   PubMed Web of Science ®Google Scholar
• WangSYYeXOuWLinYBZhangBBYangHRisk of cerebral metastases for postoperative locally advanced non-small-cell lung cancerLung Cancer200964223824318838190
   PubMed Web of Science ®Google Scholar
• HubbsJLBoydJAHollisDChinoJPSaynakMKelseyCRFactors associated with the development of brain metastases: analysis of 975 patients with early stage nonsmall cell lung cancerCancer2010116215038504620629035
   PubMed Web of Science ®Google Scholar
• LagerwaardFJLevendagPCNowakPJEijkenboomWMHanssensPESchmitzPIIdentification of prognostic factors in patients with brain metastases: a review of 1292 patientsInt J Radiat Oncol Biol Phys199943479580310098435
   PubMed Web of Science ®Google Scholar
• PatchellRATibbsPAWalshJWA randomized trial of surgery in the treatment of single metastases to the brainN Engl J Med199032284945002405271
   PubMed Web of Science ®Google Scholar
• AndrewsDWScottCBSperdutoPWWhole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialLancet200436394221665167215158627
   PubMed Web of Science ®Google Scholar
• HottaKKiuraKUeokaHEffect of gefitinib (‘Iressa’, ZD1839) on brain metastases in patients with advanced non-small-cell lung cancerLung Cancer200446225526115474674
   PubMed Web of Science ®Google Scholar
• LeeDHHanJYLeeHGGefitinib as a first-line therapy of advanced or metastatic adenocarcinoma of the lung in never-smokersClin Cancer Res20051183032303715837758
   PubMed Web of Science ®Google Scholar
• ArnoldSMYoungABMunnRKPatchellRANanayakkaraNMarkesberyWRExpression of p53, bcl-2, E-cadherin, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastasisClin Cancer Res19995124028403310632335
   PubMed Web of Science ®Google Scholar
• SaadAGYeapBYThunnissenFBImmunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinomaCancer200811382129213818720359
   PubMed Web of Science ®Google Scholar
• SicaGLChoiIHZhuGB7-H4, a molecule of the B7 family, negatively regulates T cell immunityImmunity200318684986112818165
   PubMed Web of Science ®Google Scholar
• ZangXLokePKimJMurphyKWaitzRAllisonJPB7x: a widely expressed B7 family member that inhibits T cell activationProc Natl Acad Sci USA200310018103881039212920180
   PubMed Web of Science ®Google Scholar
• PrasadDVRichardsSMaiXMDongCB7S1, a novel B7 family member that negatively regulates T cell activationImmunity200318686387312818166
   PubMed Web of Science ®Google Scholar
• QuandtDFiedlerEBoettcherDMarschWCSeligerBB7-H4 Expression in Human Melanoma: Its Association with Patients’ Survival and Antitumor Immune ResponseClin Cancer Res201117103100311121378130
   PubMed Web of Science ®Google Scholar
• TringlerBZhuoSPilkingtonGB7-h4 is highly expressed in ductal and lobular breast cancerClin Cancer Res20051151842184815756008
   PubMed Web of Science ®Google Scholar
• SunYWangYZhaoJB7-H3 and B7-H4 expression in non-small-cell lung cancerLung Cancer200653214315116782226
   PubMed Web of Science ®Google Scholar
• TringlerBLiuWCorralLB7-H4 overexpression in ovarian tumorsGynecol Oncol20061001445216256178
   PubMed Web of Science ®Google Scholar
• KrambeckAEThompsonRHDongHB7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survivalProc Natl Acad Sci USA200610327103911039616798883
   PubMed Web of Science ®Google Scholar
• ZangXThompsonRHAl-AhmadieHAB7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcomeProc Natl Acad Sci USA200710449194581946318042703
   PubMed Web of Science ®Google Scholar
• ChenLJSunJWuHYB7-H4 expression associates with cancer progression and predicts patient’s survival in human esophageal squamous cell carcinomaCancer Immunol Immunother20116071047105521519829
   PubMed Web of Science ®Google Scholar
• AwadallahNSShroyerKRLangerDADetection of B7-H4 and p53 in pancreatic cancer: potential role as a cytological diagnostic adjunctPancreas200836220020618376314
   PubMed Web of Science ®Google Scholar
• JiangJZhuYWuCTumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancerCancer Immunol Immunother201059111707171420725832
   PubMed Web of Science ®Google Scholar
• GasparLScottCRotmanMRecursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trialsInt J Radiat Oncol Biol Phys19973747457519128946
   PubMed Web of Science ®Google Scholar
• SalcedaSTangTKmetMThe immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformationExp Cell Res2005306112814115878339
   PubMed Web of Science ®Google Scholar
• KryczekIWeiSZhuGRelationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinomaCancer Res200767188900890517875732
   PubMed Web of Science ®Google Scholar
• YaoYWangXJinKB7-H4 is preferentially expressed in non-dividing brain tumor cells and in a subset of brain tumor stem-like cellsJ Neurooncol200889212112918478183
   PubMed Web of Science ®Google Scholar
• WangXHaoJMetzgerDLB7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT ActivationPLoS One201271e2823222238573
   PubMed Web of Science ®Google Scholar
• YiKHChenLFine tuning the immune response through B7-H3 and B7-H4Immunol Rev2009229114515119426220
   PubMed Web of Science ®Google Scholar
• HodiFSO’DaySJMcDermottDFImproved survival with ipilimumab in patients with metastatic melanomaN Engl J Med2010363871172320525992
   PubMed Web of Science ®Google Scholar
• TopalianSLHodiFSBrahmerJRSafety, activity, and immune correlates of anti-PD-1 antibody in cancerN Engl J Med2012366262443245422658127
   PubMed Web of Science ®Google Scholar
• BrahmerJRTykodiSSChowLQSafety and activity of anti-PD-L1 antibody in patients with advanced cancerN Engl J Med2012366262455246522658128
   PubMed Web of Science ®Google Scholar
• ChinnaduraiRGrakouiAB7-H4 mediates inhibition of T cell responses by activated murine hepatic stellate cellsHepatology20105262177218521064155
   PubMed Web of Science ®Google Scholar
• ThompsonRHZangXLohseCMSerum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stageCancer Res200868156054605818676826
   PubMed Web of Science ®Google Scholar